Antonio Cristóbal Luque Ambrosiani

@hospitaluvrocio.es

Neurologist and Research Fellow, Neurology Unit, Movement Disorders Group, Biomedicine Institute of Seville (IBiS)/Virgen del Rocío University Hospital/CSIC/University of Seville
Hospital Universitario Virgen del Rocío, Servicio Andaluz de Salud

Antonio Cristóbal Luque Ambrosiani


                        Download Compact PDF  
https://researchid.co/acluqueambrosiani
- Neurologist, Neurology Unit, Virgen del Rocío University Hospital.
- Research Fellow, Movement Disorders Group, Biomedicine Institute of Seville (IBiS)/Virgen del Rocío University Hospital/CSIC/University of Seville.

EDUCATION

Neurology residency training at Virgen del Rocío University Hospital, Seville, Spain (2021-2025)

RESEARCH, TEACHING, or OTHER INTERESTS

Neurology (clinical)
9

Scopus Publications

38

Scholar Citations

3

Scholar h-index

1

Scholar i10-index

Scopus Publications

  • Predictors of functional disability in nitrous oxide induced myeloneuropathy: an observational study
    Ignacio Lopera-Rodríguez, Alicia Silva-Cátedra, Alexandra Rincón-Valencia, Lucía García-Granados, Javier Ciriero-Macías, Elena Guijarro-Albaladejo, Carlota Villar-Rodríguez, Jorge Román-Rueda, Josefina Andrada-Moreno, Antonio Cristóbal Luque-Ambrosiani, Joaquín Arzalluz-Luque, Francisco Javier Gómez-Fernández, Carmen Paradas
    Neuromuscular Disorders, 2026
  • West Nile Virus infection in the province of Seville. An emergent infection in Spain
    Ana Caro-Leiro, Pedro María Martínez Pérez-Crespo, Manuela Aguilar-Guisado, Cristina Roca Oporto, Carmen Lozano Domínguez, Laura Merino Diaz, Reinaldo Espíndola Gómez, Elena Rubio Martín, Antonio Cristóbal Luque-Ambrosiani, Encarnación Ramírez de Arellano, Carmen Infante Domínguez, María Carmen Macías-Barrera, José Antonio Lepe, Nicolás Merchante Gutiérrez, José Miguel Cisneros
    Journal of Infection and Public Health, 2026
    INTRODUCTION: West Nile Virus (WNV) is becoming a severe problem in Europe. In 2020 and 2024, two unexpected and large outbreaks occurred in southern Spain, with a high rate of West Nile Neuroinvasive Disease (WNND). OBJECTIVE: The aim of this study is to describe clinical and prognostic features of WNV infection. MATERIALS AND METHODS: Retrospective multicentric cohort study of patients diagnosed with WNV infection in Seville (Spain) between 2020 and 2024. RESULTS: 196 patients, 58.2 % of males, were diagnosed with WNV disease with a median age of 70 (49-78) for WNND and 46 (33-65) for West Nile Fever (WNF). One hundred eight patients (55.1 %) had associated comorbidity, including 22 (11.2 %) immunocompromised patients. 138 (70.4 %) patients required hospital admission with WNND (136, 69.4 %) as the main clinical syndrome, and 33 (16.8 %) were admitted to the ICU. Twenty-five patients (12.7 %) died during their admission; all of these patients had WNND. Twenty-one of the deaths (84 %) were directly related to meningoencephalitis. One hundred (58.5 %) of the survivors had sequelae at discharge. CONCLUSION: In Spain, the first two large and unexpected outbreaks of WNV infection occurred in 2020 and 2024, resulting in high morbidity and mortality.
  • Multiple symmetric lipomatosis and axonal neuropathy in a patient with Charcot-Marie-Tooth disease due to a homozygous mutation in MFN2 gene
    Antonio Cristóbal Luque-Ambrosiani, Francisco Javier Gómez-Fernández
    Neurologia Argentina, 2025
  • Tirofiban versus aspirin to prevent in-stent thrombosis after emergent carotid artery stenting in acute ischemic stroke
    Manuel Medina-Rodriguez, Diego Villagran, Antonio Cristobal Luque-Ambrosiani, Juan Antonio Cabezas-Rodríguez, Leire Ainz-Gómez, Pablo Baena Palomino, Blanca Pardo-Galiana, Aynara Zamora, Asier de Albóniga-Chindurza, Marta Aguilar-Perez, Alejandro González, Francisco Moniche, Elena Zapata-Arriaza
    Journal of Neurointerventional Surgery, 2025
    BackgroundSeveral antithrombotic treatments during emergent carotid artery stenting (eCAS) have been proposed, but an appropriate protocol to balance risk–benefit is not well known.ObjectiveTo investigate the efficacy and safety of tirofiban compared with aspirin in patients with acute ischemic stroke undergoing eCAS.MethodsWe conducted a retrospective single-center study of the prospective ARTISTA Registry, including patients with atherosclerotic internal carotid artery occlusion treated with eCAS. Two groups, according to antiplatelet drug, were studied: aspirin (250–500 mg single-dose) versus tirofiban (500 μg bolus+200 μg/h). Primary outcomes were the rate of in-stent thrombosis and symptomatic intracranial hemorrhage (sICH) within the first 24 hours.ResultsDuring the period 2019–2023, 181 patients were included, 103 received aspirin, 78 tirofiban; 149 (82.3%) had tandem lesions. The primary efficacy outcome occurred in 9 (9.4%) in the aspirin group, as compared with 1 (1.3%) in the tirofiban group (adjusted odds ratio (aOR)=0.11, 95% CI 0.01 to 0.98; P=0.048). The primary safety outcome was detected in 12 (11.7%) in the aspirin group, as compared with 2 (2.6%) in the tirofiban group (aOR=0.16, 95% CI 0.03 to 0.87; P=0.034). The tirofiban group presented a lower risk of parenchymal hemorrhage (18 (17.4%) vs 4 (5.2%), aOR=0.27, 95% CI 0.09 to 0.88; P=0.029) and an increased rate of excellent recanalization (expanded Treatment in Cerebral Infarction (eTICI) 2c–3) (50 (48.5%) vs 54 (69.2%); aOR=2.15, 95% CI 1.12 to 4.13; P=0.02). There were no differences in functional outcomes or mortality at 3 months.ConclusionsPeriprocedural antithrombotic therapy with tirofiban was associated with a lower risk of in-stent thrombosis and sICH at 24 hours from eCAS compared with aspirin. Prospective randomized clinical trials are needed to confirm our results.
  • Clinical Presentation of Inflammatory Amyloid Angiopathy in Seville, Spain
    Luis Fernández Espigares, Antonio C. Luque Ambrosiani, Mikel Salgado Irazábal, Pablo Baena Palomino
    Alzheimer Disease and Associated Disorders, 2025
    ICAA is an underdiagnosed inflammatory response to β-amyloid (Aβ) deposition in the cortical and leptomeningeal microcirculation, and is clinically heterogeneous. We present a retrospective observational study conducted at a tertiary center from 2011 to 2024, including 11 patients who met the 2016 clinicoradiological criteria. Eleven patients were included in the study. Seven patients (64%) were female. The mean age was 70.6 years. The most frequent symptoms were seizures (n=9, 82%) and headaches (n=8, 73%). All patients presented with cortical microbleeds and white matter hyperintensities in MRI. Cortical and leptomeningeal biopsies were performed in 2 cases due to diagnostic uncertainty. Corticosteroid therapy was used in 9 (82%) patients, but clinical relapse occurred in 55%, and 45% were functionally dependent after 1 year. This case series highlights the heterogeneous clinical and radiologic presentation of ICAA and the challenges in its diagnosis and management, highlighting the need for standardized therapeutic approaches and further research to improve its prognosis.
  • Understanding Parkinson disease in Spain: Genetic and clinical insights
    Pilar Gómez‐Garre, Miguel Martín‐Bórnez, Laura Muñoz‐Delgado, Rafael Díaz‐Belloso, María Teresa Periñán, Marta Bonilla‐Toribio, Dolores Buiza‐Rueda, Daniel Macías‐García, Silvia Jesús, Astrid Adarmes‐Gómez, Elena Ojeda, Antonio Luque‐Ambrosiani, Sergio García‐Díaz, Rocío Pineda Sánchez, Fátima Carrillo, Pablo Mir
    European Journal of Neurology, 2025
    Background and purposeParkinson disease (PD) is a complex and heterogeneous neurodegenerative disorder with a broad spectrum of clinical manifestations, determined by a complex interplay of environmental and genetic factors. This study aimed to investigate genetic variants associated with PD and assess their impact on the disease phenotype through genotype–phenotype correlations.MethodsWe employed a targeted resequencing panel to analyze 27 genes linked to PD in a cohort of 1185 PD patients from southern Spain. Variants were categorized based on the American College of Medical Genetics and Genomics pathogenicity criteria. Demographic and clinical data were also collected.ResultsAmong the patients analyzed, 13.5% carried potential disease‐causing pathogenic or likely pathogenic variants in 12 different genes, indicating significant genetic heterogeneity. The most frequently affected genes were LRRK2, PRKN, and GBA1 (accounting for 72.1% of positive cases). Sex‐specific differences were observed, with a higher proportion of female patients carrying LRRK2 variants. Differences in age at onset and clinical features were also observed among the different mutated genes. Notably, variants in genes associated with atypical parkinsonism presented distinct clinical presentations, highlighting the importance of genetic factors in the differential diagnosis.ConclusionsOur study provides valuable information on the genetic landscape of PD and its clinical manifestations. The observed genotype–phenotype correlations, along with sex‐specific differences, emphasize the complexity of PD pathogenesis, underlining the importance of personalized approaches to PD diagnosis and treatment. Further investigations into genetic interactions and population‐specific effects are warranted to enhance our understanding of PD etiology and improve patient care.
  • Peripheral immune profile and neutrophil-to-lymphocyte ratio in progressive supranuclear palsy: Case–control study and meta-analysis
    Laura Muñoz‐Delgado, Antonio Luque‐Ambrosiani, Belén Benítez Zamora, Daniel Macías‐García, Silvia Jesús, Astrid Adarmes‐Gómez, Elena Ojeda‐Lepe, Fátima Carrillo, Pablo Mir
    European Journal of Neurology, 2024
    Background and purposePeripheral inflammation is probably involved in the pathogenesis of progressive supranuclear palsy (PSP) and it may be a common feature with Parkinson's disease (PD). The peripheral immune profile in PSP remains unclear, as well as whether the inflammatory pathways differ from those in PD. The neutrophil‐to‐lymphocyte ratio (NLR) has been proven to be a well‐established biomarker of systemic inflammation. This study aimed to evaluate the peripheral immune profile in PSP compared with PD.MethodsA cross‐sectional study was conducted including patients with PSP and PD and healthy controls (HCs). Leukocyte subpopulations and the NLR were measured in peripheral blood. Multivariate linear regression and post hoc tests were applied. Electronic databases were searched in November 2023 to perform meta‐analyses to clarify the peripheral immune profile in PSP.ResultsOur cohort included 121 patients with PSP, 127 patients with PD and 266 HCs. The NLR was higher in PSP and PD compared with HCs. PSP had a higher neutrophil count compared with HCs. Whilst a lower lymphocyte count was found in PD compared with HCs, the lymphocyte count did not differ between PSP and HCs. The meta‐analyses supported this immune profile.ConclusionsPSP and PD show an increased peripheral inflammation and a higher NLR compared with HCs. Different pathogenic inflammatory mechanisms are probably involved in PSP and PD, since in PSP this altered peripheral immune profile is mainly driven by neutrophils. Understanding the neutrophils' role in PSP may allow for the development of targeted therapies.
  • Review of a series of cases of Creutzfeldt-Jakob disease in a tertiary care hospital
    Diego Villagrán Sancho, F. J. Gómez Fernández, Antonio C. Luque Ambrosiani, Francisco J. Hernández Chamorro, Emilio Franco Macías, María Bernal Sánchez-Arjona
    Revista De Neurologia, 2023
    Introducción. Analizamos en nuestro medio una serie de pacientes con enfermedad de Creutzfeldt-Jakob esporádica. Objetivo. Describir las características de nuestra muestra haciendo uso de las nuevas herramientas diagnósticas según los últimos criterios publicados. Material y métodos. Realizamos un estudio descriptivo y retrospectivo mediante registro hospitalario digitalizado. Identificamos 20 casos del tipo esporádico, en el período 2012-2022, ocho con diagnóstico anatomopatológico y 12 con alta probabilidad. Se registraron las variables sexo, edad de inicio, tiempo de evolución, fenotipo clínico, hallazgos en la resonancia magnética (RM), proteína 14.3.3, electroencefalograma (EEG), conversión de proteína priónica inducida por agitación en tiempo real (RT-QuIC), autopsia, fenotipo anatomopatológico y diagnóstico genético. Resultados. Registramos un 50% de hombres y un 50% de mujeres afectos, con una edad de inicio de 67 años (30-83) y un tiempo de supervivencia medio de ocho meses (1-11 meses). El deterioro cognitivo fue el síntoma de inicio más frecuente, seguido de la ataxia de la marcha. Todas las RM con secuencias de tiempo de repetición largo (FLAIR y DWI) fueron patológicas, y el patrón de afectación cortical difusa y de los ganglios basales fue el más frecuente. El 55% de la muestra tuvo un EEG con complejos trifásicos característicos. El 65% mostró positiva la proteína 14.3.3 en el líquido cefalorraquídeo. Se realizaron cuatro estudios de RT-QuIC (en 2020) y todos fueron positivos. En un 40% se realizó una autopsia confirmatoria, con el patrón MM/MV1 como el más frecuente. Conclusiones. La RM con secuencias de DWI constituye una prueba especialmente sensible para el diagnóstico de la enfermedad, aunque su sensibilidad disminuye en estadios precoces. La alta especificidad y la alta sensibilidad de la RT-QuIC, junto con un diagnóstico clínico y patrón radiológico característico, se plantean como alternativa al diagnóstico de certeza anatomopatológico.
  • Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report
    Diego Villagrán Sancho, Antonio C. Luque Ambrosiani, C. Mayorga Morón, F. J. Gómez Fernández, J. Arzalluz Luque, Amaya Castela Murillo, Francisco J. Hernández Ramos, Mª Dolores Jiménez Hernández, Alfredo Palomino García
    Revista De Neurologia, 2023
    Introducción. El estado epiléptico superrefractario de nueva aparición (NOSRSE) es una emergencia neurológica caracterizada por el desarrollo de estado epiléptico en un paciente sin epilepsia ni enfermedad neurológica previa conocida y sin clara causa estructural, tóxica o metabólica, que recurre tras 24 horas del coma inducido. La causa identificable más frecuente es la inflamatoria-autoinmune. En consecuencia, planteamos un caso de NOSRSE relacionado con la vacunación para el SARS-CoV-2 como una oportunidad de indagar el origen disinmune de esta patología. Caso clínico. Varón de 40 años que acude al servicio de urgencias refiriendo fiebre y cefalea sin claro foco infeccioso. Entre sus antecedentes personales destacamos una meningitis bacteriana en la infancia sin secuelas y un déficit de proteína S sin tratamiento en ese momento, así como vacunación con ChAdOx1 nCoV-19 21 días antes. Fue inicialmente diagnosticado de infección del tracto urinario y tratado con cefuroxima. Dos días después, se le llevó de nuevo a urgencias con cuadro confusional y crisis tonicoclónicas, sin respuesta al midazolam, y requirió finalmente sedación e intubación orotraqueal por estado epiléptico refractario. Durante su ingreso requirió múltiples líneas de antiepilépticos, quetamina, dieta cetógena, inmunoterapia y plasmaféresis para conseguir limitar el NOSRSE. El estudio etiológico ofrecía normalidad de los resultados de serología, anticuerpos antineuronales en el suero y líquido cefalorraquídeo, ecocardiografía transtorácica, ecografía testicular y angiotomografía computarizada. Únicamente la resonancia magnética de control mostró una alteración difusa y bilateral de la corteza hemisférica y pulvinar talámica derecha como único hallazgo. Conclusión. Es crucial notificar las sospechas de reacciones adversas asociadas a la vacunación frente al SARS-CoV-2, permitiendo así una supervisión continuada de la relación riesgo/beneficio de ésta.

RECENT SCHOLAR PUBLICATIONS

  • Predictors of functional disability in nitrous oxideinduced myeloneuropathy: an observational study
    I Lopera-Rodríguez, A Silva-Cátedra, A Rincón-Valencia, ...
    Neuromuscular Disorders, 106460 , 2026
    2026
  • West Nile Virus infection in the province of Seville. An emergent infection in Spain.
    A Caro-Leiro, PMM Pérez-Crespo, MA Guisado, CR Oporto, ...
    Journal of Infection and Public Health, 103072 , 2025
    2025
  • Lipomatosis múltiple simétrica y neuropatía axonal en paciente con enfermedad de Charcot-Marie-Tooth debida a mutación homocigota en MFN2
    AC Luque-Ambrosiani, FJ Gómez-Fernández
    Neurología Argentina , 2025
    2025
  • 22462-MIOPATÍA INFLAMATORIA ASOCIADA A ANTI-TIF1?: DE LA PIEL AL HALLAZGO ONCOLÓGICO A TRAVÉS DEL DIAGNÓSTICO NEUROLÓGICO
    LM Hernández, A Luque-Ambrosiani, DV Sancho, FG Fernández, ...
    Neurology Perspectives 5, 111580 , 2025
    2025
  • Clinical Presentation of Inflammatory Amyloid Angiopathy in Seville, Spain: A Case Series
    LF Espigares, ACL Ambrosiani, MS Irazábal, PB Palomino
    Alzheimer Disease & Associated Disorders 39 (4), 324-327 , 2025
    2025
  • West Nile Virus Neuroinvasive Disease: A Retrospective Analysis of Hospitalized Cases in a Tertiary Care Center in Southern Europe
    AC Luque-Ambrosiani, I Lopera-Rodríguez, A Fernández-Panadero, ...
    Revista de Neurología 80 (8), 36787 , 2025
    2025
    Citations: 1
  • Tirofiban versus aspirin to prevent in-stent thrombosis after emergent carotid artery stenting in acute ischemic stroke
    M Medina-Rodriguez, D Villagran, AC Luque-Ambrosiani, ...
    Journal of NeuroInterventional Surgery 17 (7), 697-702 , 2025
    2025
    Citations: 14
  • Metronidazole-induced toxicity of the central and peripheral nervous system
    D Villagrán Sancho, C Villar Rodríguez, AC Luque Ambrosiani, ...
    BMJ Case Reports 18 (6), e264904 , 2025
    2025
    Citations: 2
  • Encefalitis antiGAD65 y miastenia-miositis-miocarditis seropositiva, doble síndrome paraneoplásico secundario a timoma
    FJ Hernández Chamorro, A Luque-Ambrosiani, FJ Hernández-Ramos
    Ergon , 2025
    2025
  • Más allá de la enzima: debilidad axial progresiva en un adolescente con diagnóstico previo de enfermedad de Pompe
    A Luque-Ambrosiani, M Salgado Irazabal, FJ Gómez Fernández
    Ergon , 2025
    2025
  • Enfermedad Neuroinvasiva por Virus del Nilo Occidental: Análisis Retrospectivo de Casos Hospitalizados en un Centro de Tercer Nivel del Sur de Europa
    ACL Ambrosiani, IL Rodríguez, AF Panadero, MST Gómez, MS Irazabal, ...
    Revista de neurología 80 (8), 6 , 2025
    2025
  • Enfermedad Neuroinvasiva por Virus del Nilo Occidental: Análisis Retrospectivo de Casos Hospitalizados en un Centro de Tercer Nivel del Sur de Europa
    AC Luque-Ambrosiani, I Lopera-Rodríguez, A Fernández-Panadero, ...
    Rev. Neurol 80 (8), 36787 , 2025
    2025
  • Ganglioneuroma como diagnóstico diferencial de lesiones del espacio carotídeo: reporte de caso Ganglioneuroma as a differential diagnosis of carotid space lesions: case report
    AC Luque-Ambrosiani, S Flores-Fernández
    Rev Argent Radiol 89 (4), 246-248 , 2025
    2025
  • Peripheral immune profile and neutrophil‐to‐lymphocyte ratio in progressive supranuclear palsy: Case–control study and meta‐analysis
    L Muñoz‐Delgado, A Luque‐Ambrosiani, BB Zamora, D Macías‐García, ...
    European Journal of Neurology 31 (12), e16451 , 2024
    2024
    Citations: 9
  • Understanding Parkinson disease in Spain: Genetic and clinical insights
    P Gómez-Garre, M Martín-Bórnez, L Muñoz-Delgado, R Díaz-Belloso, ...
    European Journal of Neurology, e16499 , 2024
    2024
    Citations: 7
  • Peripheral Immune Profile and Neutrophil-to-Lymphocyte Ratio in Progressive Supranuclear Palsy
    L Munoz-Delgado, A Luque-Ambrosiani, BB Zamora, D Macias-Garcia, ...
    MOVEMENT DISORDERS 39, S28-S28 , 2024
    2024
  • Understanding Parkinson's disease (PD) in Spain: Genetic and Clinical Insights
    M Martin-Bornez, L Munoz-Delgado, R Diaz-Belloso, MT Perinan, ...
    MOVEMENT DISORDERS 39, S784-S784 , 2024
    2024
  • Effect of Bilateral Internal Segment of the Globus Pallidus Deep Brain Stimulation on Acquired Multifocal Dystonia Due to Natural Gas Intoxication
    A Luque-Ambrosiani, D Macias-Garcia, F Carrillo, L Munoz-Delgado, ...
    MOVEMENT DISORDERS 39, S643-S643 , 2024
    2024
  • Review of a series of cases of Creutzfeldt-Jakob disease in a tertiary care hospital
    D Villagrán-Sancho, FJ Gómez-Fernández, AC Luque-Ambrosiani, ...
    Revista de Neurología 77 (12), 299 , 2023
    2023
  • Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report
    D Villagrán-Sancho, AC Luque-Ambrosiani, C Mayorga-Morón, ...
    Revista de Neurología 76 (12), 399 , 2023
    2023
    Citations: 1

MOST CITED SCHOLAR PUBLICATIONS

  • Tirofiban versus aspirin to prevent in-stent thrombosis after emergent carotid artery stenting in acute ischemic stroke
    M Medina-Rodriguez, D Villagran, AC Luque-Ambrosiani, ...
    Journal of NeuroInterventional Surgery 17 (7), 697-702 , 2025
    2025
    Citations: 14
  • Peripheral immune profile and neutrophil‐to‐lymphocyte ratio in progressive supranuclear palsy: Case–control study and meta‐analysis
    L Muñoz‐Delgado, A Luque‐Ambrosiani, BB Zamora, D Macías‐García, ...
    European Journal of Neurology 31 (12), e16451 , 2024
    2024
    Citations: 9
  • Understanding Parkinson disease in Spain: Genetic and clinical insights
    P Gómez-Garre, M Martín-Bórnez, L Muñoz-Delgado, R Díaz-Belloso, ...
    European Journal of Neurology, e16499 , 2024
    2024
    Citations: 7
  • Revisión de una serie de casos de enfermedad de Creutzfeldt-Jakob en un hospital de tercer nivel
    DV Sancho, FJG Fernández, FJH Chamorro, EF Macías, MBS Arjona
    Revista de neurología 77 (12), 299-304 , 2023
    2023
    Citations: 3
  • Metronidazole-induced toxicity of the central and peripheral nervous system
    D Villagrán Sancho, C Villar Rodríguez, AC Luque Ambrosiani, ...
    BMJ Case Reports 18 (6), e264904 , 2025
    2025
    Citations: 2
  • West Nile Virus Neuroinvasive Disease: A Retrospective Analysis of Hospitalized Cases in a Tertiary Care Center in Southern Europe
    AC Luque-Ambrosiani, I Lopera-Rodríguez, A Fernández-Panadero, ...
    Revista de Neurología 80 (8), 36787 , 2025
    2025
    Citations: 1
  • Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report
    D Villagrán-Sancho, AC Luque-Ambrosiani, C Mayorga-Morón, ...
    Revista de Neurología 76 (12), 399 , 2023
    2023
    Citations: 1
  • Estado epiléptico superrefractario de nueva aparición criptógeno tras vacunación contra el SARS-CoV-2. A propósito de un caso
    D Villagrán-Sancho, AC Luque-Ambrosiani, C Mayorga-Morón, ...
    Rev. neurol.(Ed. impr.), 399-402 , 2023
    2023
    Citations: 1
  • Predictors of functional disability in nitrous oxideinduced myeloneuropathy: an observational study
    I Lopera-Rodríguez, A Silva-Cátedra, A Rincón-Valencia, ...
    Neuromuscular Disorders, 106460 , 2026
    2026
  • West Nile Virus infection in the province of Seville. An emergent infection in Spain.
    A Caro-Leiro, PMM Pérez-Crespo, MA Guisado, CR Oporto, ...
    Journal of Infection and Public Health, 103072 , 2025
    2025
  • Lipomatosis múltiple simétrica y neuropatía axonal en paciente con enfermedad de Charcot-Marie-Tooth debida a mutación homocigota en MFN2
    AC Luque-Ambrosiani, FJ Gómez-Fernández
    Neurología Argentina , 2025
    2025
  • 22462-MIOPATÍA INFLAMATORIA ASOCIADA A ANTI-TIF1?: DE LA PIEL AL HALLAZGO ONCOLÓGICO A TRAVÉS DEL DIAGNÓSTICO NEUROLÓGICO
    LM Hernández, A Luque-Ambrosiani, DV Sancho, FG Fernández, ...
    Neurology Perspectives 5, 111580 , 2025
    2025
  • Clinical Presentation of Inflammatory Amyloid Angiopathy in Seville, Spain: A Case Series
    LF Espigares, ACL Ambrosiani, MS Irazábal, PB Palomino
    Alzheimer Disease & Associated Disorders 39 (4), 324-327 , 2025
    2025
  • Encefalitis antiGAD65 y miastenia-miositis-miocarditis seropositiva, doble síndrome paraneoplásico secundario a timoma
    FJ Hernández Chamorro, A Luque-Ambrosiani, FJ Hernández-Ramos
    Ergon , 2025
    2025
  • Más allá de la enzima: debilidad axial progresiva en un adolescente con diagnóstico previo de enfermedad de Pompe
    A Luque-Ambrosiani, M Salgado Irazabal, FJ Gómez Fernández
    Ergon , 2025
    2025
  • Enfermedad Neuroinvasiva por Virus del Nilo Occidental: Análisis Retrospectivo de Casos Hospitalizados en un Centro de Tercer Nivel del Sur de Europa
    ACL Ambrosiani, IL Rodríguez, AF Panadero, MST Gómez, MS Irazabal, ...
    Revista de neurología 80 (8), 6 , 2025
    2025
  • Enfermedad Neuroinvasiva por Virus del Nilo Occidental: Análisis Retrospectivo de Casos Hospitalizados en un Centro de Tercer Nivel del Sur de Europa
    AC Luque-Ambrosiani, I Lopera-Rodríguez, A Fernández-Panadero, ...
    Rev. Neurol 80 (8), 36787 , 2025
    2025
  • Ganglioneuroma como diagnóstico diferencial de lesiones del espacio carotídeo: reporte de caso Ganglioneuroma as a differential diagnosis of carotid space lesions: case report
    AC Luque-Ambrosiani, S Flores-Fernández
    Rev Argent Radiol 89 (4), 246-248 , 2025
    2025
  • Peripheral Immune Profile and Neutrophil-to-Lymphocyte Ratio in Progressive Supranuclear Palsy
    L Munoz-Delgado, A Luque-Ambrosiani, BB Zamora, D Macias-Garcia, ...
    MOVEMENT DISORDERS 39, S28-S28 , 2024
    2024
  • Understanding Parkinson's disease (PD) in Spain: Genetic and Clinical Insights
    M Martin-Bornez, L Munoz-Delgado, R Diaz-Belloso, MT Perinan, ...
    MOVEMENT DISORDERS 39, S784-S784 , 2024
    2024